pacira-bioscience-logO.png
New Retrospective Analysis Shows EXPAREL Associated with Significantly Less Opioid Use Following Third Molar Extraction
June 26, 2019 07:30 ET | Pacira BioSciences
PARSIPPANY, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced results of a new analysis of patients undergoing elective third molar (“wisdom teeth”)...
Pacira_logo[1].JPG
EXPAREL Achieves Statistically Significant Reductions in Opioid Consumption and Pain Scores in Cesarean Section Patients
January 16, 2019 07:30 ET | Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that its Phase 4 study of EXPAREL® (bupivacaine liposome injectable suspension) in...
Pacira_logo[1].JPG
Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers 
October 30, 2018 07:30 ET | Pacira Pharmaceuticals, Inc.
Aetna will reimburse for the use of EXPAREL in ambulatory surgical centers in Florida and New Jersey as part of a pilot program       PARSIPPANY, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aetna has...
pacira-bioscience-logO.png
New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to Treat Postsurgical Pain if Given the Option
May 03, 2017 11:00 ET | Pacira Pharmaceuticals, Inc
PARSIPPANY, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- According to a new national survey of over 1,500 oral surgery patients or their parents, more than seven in 10 respondents indicated they would opt...
Plastic Surgeon in Manhattan Reveals Customized Approach to Mommy Makeovers
March 18, 2014 09:01 ET | Stafford R. Broumand, MD
NEW YORK, NY--(Marketwired - Mar 18, 2014) - "The process of restoring one's body to its pre-pregnancy form can be difficult and often frustrating," says Manhattan plastic surgeon Stafford R....